B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis

NCT06612411 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Irritable Bowel Syndrome with Diarrhea
Purine Metabolism Disorder

Interventions

DRUG: B. subtilis
DRUG: Dead B. subtilis

Sponsor

Jinling Hospital, China